Table 4 -. Top Most significant enriched pathways.
Category | Id | Term | Count | Genes | P-valuea |
---|---|---|---|---|---|
Upregulated | |||||
K | hsa00480 | Glutathione metabolism | 3 | GSR|GPX4|GPX1 | 8.46E-06 |
R | HSA-2142770 | Synthesis of 15-eicosatetraenoic acid derivatives | 2 | GPX4|GPX1 | 7.05E-05 |
R | HSA-2142712 | Synthesis of 12-eicosatetraenoic acid derivatives | 2 | GPX4|GPX1 | 7.05E-05 |
R | HSA-2142688 | Synthesis of 5-eicosatetraenoic acids | 2 | GPX4|GPX1 | 7.05E-05 |
R | HSA-3299685 | Detoxification of Reactive Oxygen Species | 2 | SOD1|GPX1 | 4.20E-04 |
K | hsa05014 | Amyotrophic lateral sclerosis (ALS) | 2 | SOD1|GPX1 | 9.40E-04 |
K | hsa04918 | Thyroid hormone synthesis | 2 | GSR|GPX1 | 0.0013 |
R | HSA-114608 | Platelet degranulation | 2 | SOD1|SEPP1 | 0.0033 |
K | hsa05016 | Huntington’s disease | 2 | SOD1|GPX1 | 0.0065 |
Downregulated | |||||
R | HSA-3299685 | Detoxification of Reactive Oxygen Species | 2 | CAT|SOD2 | 6.61E-5 |
K | hsa04146 | Peroxisome | 2 | CAT|SOD2 | 9.18E-5 |
K | hsa04211 | Longevity regulating pathway | 2 | CAT|SOD2 | 9.18E-5 |
K | hsa04068 | FoxO signaling pathway | 2 | CAT|SOD2 | 1.0E-4 |
R | HSA-2262752 | Cellular responses to stress | 2 | CAT|SOD2 | 0.003 |
R | HSA-8953897 | Cellular responses to external stimuli | 2 | CAT|SOD2 | 0.003 |
R | HSA-168256 | Immune System | 2 | CAT|SOD2 | 0.046 |
K, KEGG Pathways; R, REACTOME Pathways; a Corrected p-value